Avidity Biosciences, Inc.Avidity Biosciences, Inc.Avidity Biosciences, Inc.

Avidity Biosciences, Inc.

No trades
See on Supercharts

Price target

43.860.00 0.00%
The 7 analysts offering 1 year price forecasts for RNA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to RNA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

RNA EPS for the last quarter is −0.79 USD despite the estimation of −0.66 USD. In the next quarter EPS is expected to reach −0.80 USD. Track more of Avidity Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Avidity Biosciences, Inc. revenue is expected to reach ‪2.57 M‬ USD. Check out Avidity Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, RNA price target is 43.86 USD with a max estimate of 71.00 USD and a min estimate of 18.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with RNA news and stock market news.
We've gathered opinions of 8 analysts rating RNA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.